Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

High concentration formulations of adalimumab

US Patent 11229702 · Granted Jan 25, 2022

Estimated economic value: $8,853,000

Assignee

Inventors

View full patent text on Google Patents →